Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Assets (2016 - 2022)

Historic Return on Assets for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to 0.15%.

  • Avadel Pharmaceuticals' Return on Assets rose 900.0% to 0.15% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.15%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.31% for FY2021, which is 2800.0% down from last year.
  • As of Q3 2022, Avadel Pharmaceuticals' Return on Assets stood at 0.15%, which was up 900.0% from 0.26% recorded in Q2 2022.
  • Avadel Pharmaceuticals' 5-year Return on Assets high stood at 0.1% for Q1 2018, and its period low was 0.6% during Q2 2019.
  • Moreover, its 5-year median value for Return on Assets was 0.25% (2021), whereas its average is 0.25%.
  • In the last 5 years, Avadel Pharmaceuticals' Return on Assets plummeted by -6700bps in 2018 and then skyrocketed by 5200bps in 2020.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' Return on Assets stood at 0.41% in 2018, then decreased by -19bps to 0.49% in 2019, then surged by 104bps to 0.02% in 2020, then crashed by -1804bps to 0.34% in 2021, then skyrocketed by 56bps to 0.15% in 2022.
  • Its Return on Assets stands at 0.15% for Q3 2022, versus 0.26% for Q2 2022 and 0.31% for Q1 2022.